Daniel Arias
Stock Analyst at Stifel
(5.00)
# 7
Out of 5,031 analysts
158
Total ratings
58.89%
Success rate
148.73%
Average return
Main Sectors:
Stocks Rated by Daniel Arias
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Buy | $60 → $70 | $65.46 | +6.94% | 4 | Sep 25, 2025 | |
| BRKR Bruker | Maintains: Hold | $48 → $40 | $36.98 | +8.17% | 9 | Aug 5, 2025 | |
| AVTR Avantor | Maintains: Hold | $14 → $12 | $14.78 | -18.81% | 10 | Aug 4, 2025 | |
| RVTY Revvity | Maintains: Hold | $120 → $110 | $93.42 | +17.75% | 2 | Jul 29, 2025 | |
| TECH Bio-Techne | Maintains: Hold | $75 → $60 | $61.86 | -3.01% | 11 | May 8, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $665 → $620 | $538.92 | +15.04% | 16 | Apr 24, 2025 | |
| DHR Danaher | Upgrades: Buy | $260 | $209.06 | +24.37% | 10 | Mar 14, 2025 | |
| MXCT MaxCyte | Maintains: Buy | $11 → $9 | $1.61 | +459.01% | 2 | Mar 12, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $21 → $18 | $11.83 | +52.16% | 6 | Feb 13, 2025 | |
| MASS 908 Devices | Maintains: Buy | $17 → $6 | $8.56 | -29.91% | 2 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,550 → $1,450 | $1,349.28 | +7.46% | 7 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $45 → $65 | $87.78 | -25.95% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $82 → $67 | $61.23 | +9.42% | 6 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $332 → $360 | $334.59 | +7.59% | 16 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $163 → $151 | $141.92 | +6.40% | 20 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $57 → $46 | $48.27 | -3.98% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $3.30 | +203.03% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $165 → $207 | $152.60 | +35.65% | 9 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $200 | $95.46 | +109.51% | 16 | Oct 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $5 | $2.65 | +88.68% | 2 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $10 | $4.53 | +120.75% | 2 | May 31, 2022 |
Guardant Health
Sep 25, 2025
Maintains: Buy
Price Target: $60 → $70
Current: $65.46
Upside: +6.94%
Bruker
Aug 5, 2025
Maintains: Hold
Price Target: $48 → $40
Current: $36.98
Upside: +8.17%
Avantor
Aug 4, 2025
Maintains: Hold
Price Target: $14 → $12
Current: $14.78
Upside: -18.81%
Revvity
Jul 29, 2025
Maintains: Hold
Price Target: $120 → $110
Current: $93.42
Upside: +17.75%
Bio-Techne
May 8, 2025
Maintains: Hold
Price Target: $75 → $60
Current: $61.86
Upside: -3.01%
Thermo Fisher Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $665 → $620
Current: $538.92
Upside: +15.04%
Danaher
Mar 14, 2025
Upgrades: Buy
Price Target: $260
Current: $209.06
Upside: +24.37%
MaxCyte
Mar 12, 2025
Maintains: Buy
Price Target: $11 → $9
Current: $1.61
Upside: +459.01%
10x Genomics
Feb 13, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $11.83
Upside: +52.16%
908 Devices
Nov 13, 2024
Maintains: Buy
Price Target: $17 → $6
Current: $8.56
Upside: -29.91%
Nov 11, 2024
Maintains: Buy
Price Target: $1,550 → $1,450
Current: $1,349.28
Upside: +7.46%
Nov 11, 2024
Downgrades: Hold
Price Target: $45 → $65
Current: $87.78
Upside: -25.95%
Nov 6, 2024
Maintains: Buy
Price Target: $82 → $67
Current: $61.23
Upside: +9.42%
Nov 4, 2024
Maintains: Hold
Price Target: $332 → $360
Current: $334.59
Upside: +7.59%
May 30, 2024
Maintains: Buy
Price Target: $163 → $151
Current: $141.92
Upside: +6.40%
May 1, 2024
Maintains: Hold
Price Target: $57 → $46
Current: $48.27
Upside: -3.98%
Feb 23, 2024
Maintains: Buy
Price Target: $11 → $10
Current: $3.30
Upside: +203.03%
Feb 22, 2024
Maintains: Buy
Price Target: $165 → $207
Current: $152.60
Upside: +35.65%
Oct 12, 2023
Reiterates: Buy
Price Target: $200
Current: $95.46
Upside: +109.51%
Aug 14, 2023
Maintains: Buy
Price Target: $9 → $5
Current: $2.65
Upside: +88.68%
May 31, 2022
Maintains: Hold
Price Target: $28 → $10
Current: $4.53
Upside: +120.75%